Background : Due to bone loss and consequent sinus pneumatization, sinus lift procedure is usually required in order to allow rehabilitation with dental implants. Considering that regenerative medicine is currently still a controversial approach, especially regarding the costeffectiveness safety and the uncertain outcomes, it is mandatory to find literature evidences of regenerative medicine in two stages sinus lift procedures through lateral window in humans. 
Aim/Hypothesis

Results : Four different cells technics were observed-Mesenchymal stem cells (MSC), Mandibular periosteum-derived cells; PepGen P-15
Putty; Recombinant human bone morphogenetic protein-7 (rhBMP-7). In 12 studies, histomorphometrically analysis were reported. The bone volume with rhBMP-7 was 34.21% ± 6.7 versus 62.88% ± 8.4% without rhBMP-7 after 4 months ( P < 0.05). Four studies found histological statistical significance differences in favor of the MSC after 3 and 6 month and for the periosteum-derived cells and Pepgen P-15 evaluated at 3 months. Two RCT split-mouth design did observed statistically significant differences between groups. Six trials included a radiological evaluation part. The use of MSCs the radiological evaluation shown a bone gain (mm)-9.8 ± 1.78 at 3 months; 8.7 ± 3.3 at 4 months; 7.8 ± 2.8 to 8.5 ± 1.44 at 12 months. In 11 study ' s the implant survival rate was reported. For MSC range between 91%-100% and 100% for PepGen P-15 and mandibular periosteum-derived cells.
Conclusion and Clinical Implications : Although there are encouraging literature results, regenerative techniques require a careful case-bycase evaluation before its use. Limitations of regenerative techniques include potential biological risks, the use of general anesthesia, second surgical side, increasing costs and recovery time, adding to the difficulty and sensitiveness of the techniques that are required for some of these cells technics manipulations. Further clinical trials are needed to achieve a more accurate evaluation.
